Commercializing KETAMINE (KETARX™) for pain, mental health, neurological, and life threatening indications.

September 2024 Investor Deck

OTCQB: PHRRF  |  CSE: PHRM

Press Releases

View more press releases

Sign up for updates

Connect With Us

PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario  Canada
M5C 1P1